Back to search

Poland· PL-100045382

Tinctura Crataegi Herbapol w Krakowie SA

A crataegus glykoside product containing crataegi tinctura, registered in Poland by Krakowskie Zakłady Zielarskie "Herbapol" w Krakowie S.A.. The same ATC class is registered in 2 of our 19 countries.

ATC C01EB04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTinctura Crataegi Herbapol w Krakowie…ATCC01EB04REGISTER NO.PL-100045382PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Crataegus glykoside is registered in 2 of 19 countries.

Countries holding a registration under ATC C01EB04 (crataegus glykoside), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Crataegus glykoside · ATC C01EB04

2 / 19 countries

  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Crataegi tinctura
Manufacturer
Krakowskie Zakłady Zielarskie "Herbapol" w Krakowie S.A.
Country
Poland (PL)
ATC code
C01EB04
ATC class
Crataegus Glykoside
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990080816
  • gtin
    05909990080823

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Crataegus glykoside in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All crataegus glykoside products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Germany · Naturreiner Heilpflanzensaft Weißdorn flüssigkeit zur Anwendung Bei Erwachsenen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f5b05422-1882-49bd-9688-c996f795d4d8
GET /v1/drugs/f5b05422-1882-49bd-9688-c996f795d4d8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Płyn doustny",
  "source": "urpl",
  "strength": "-",
  "packaging": "OTC ¦ Skasowane ¦ 6782\n1 op. 25 g\n05909990080816 ¦ OTC ¦ 6783\n1 butelka 35 ml\n05909990080823 ¦ OTC ¦ 19809\n1 butelka 100 ml",
  "substance": "Crataegi tinctura 20 %",
  "common_name": "Crataegi tinctura",
  "pl_product_id": "100045382",
  "pozwolenie_nr": "00808",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about crataegus glykoside.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.